Financial Data and Key Metrics Changes - Acadia reported a year-over-year revenue growth of 12.5%, reaching 750.3millionforQ32023[22]−AdjustedEBITDAincreasedby13.4175.9 million compared to 155.1millioninQ32022[23]−AdjustedEPSgrewby13.80.91 per diluted share, up from 0.80inthesamequarterlastyear[23]−Samefacilityrevenueincreasedby1399.6 million in cash and $520 million available under its revolving credit facility [25] - The company announced a definitive agreement to acquire Turning Point Centers, which will add 76 beds and potentially 48 more over time [15] Q&A Session Summary Question: Inquiry about professional liability reserves - Management confirmed that the increase in reserves was part of the regular review process and not due to changes in claims volume [30] Question: Update on service line performance and Medicaid redetermination - Management indicated strong performance across all service lines, with no significant impact from Medicaid redetermination on patient volume [32] Question: Thoughts on payment rates and payer classes - Management expressed satisfaction with rate negotiations, expecting continued strong rates into Q4 and 2024 [37] Question: Discussion on joint ventures and partnerships - Management noted ongoing interest from health systems in partnerships to address behavioral health needs, indicating a strong pipeline for future joint ventures [41] Question: Impact of construction costs on future growth - Management acknowledged previous spikes in construction costs but indicated improved management strategies moving forward [59] Question: Corporate overhead expectations for next year - Management expects corporate costs to level off and continue to build leverage as a percentage of revenue [65]